Yang Lin-Juan, Liu Xuan, Mi Sheng-Jian, Sun Le, Chen Meng-Xin
Department of Ophthalmology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China.
Int J Ophthalmol. 2021 Mar 18;14(3):423-429. doi: 10.18240/ijo.2021.03.15. eCollection 2021.
To compare the quality outcomes of vision at early phase after topography-guided femtosecond laser-assisted keratomileusis (FS-LASIK-CV) and small incision lenticule extraction (SMILE) in treatment of myopia and myopic astigmatism.
Retrospective comparative analysis of 49 patients that underwent FS-LASIK (=23) or SMILE (=26) procedure for myopia and myopic astigmatism between April and September in 2019. Pre- and postoperative uncorrected visual acuity (UCVA), spherical equivalent refraction (SEQ), cylindrical refraction, contrast sensitivity function (CSF), and corneal higher-order aberrations (HOAs) were evaluated. Independent -test was used for inter-group comparison, while repeated measures ANOVA was used to analyze changes at different time points.
In both groups, 100% of the eyes obtained a UCVA of 20/20 or better at 1wk, 1, and 3mo postoperatively. At 1d and 3mo postoperatively, UCVA was better in FS-LASIK-CV group than in SMILE group. At 1wk postoperatively, SEQ was lower in SMILE group than in FS-LASIK-CV group (=0.006). At 3mo postoperatively, the SEQ reached target refraction in both groups. The residual astigmatism was reduced in both groups without intergroup difference (>0.05). At 3mo postoperatively, the spherical aberration and coma under 6 mm pupil size were higher than preoperative levels in both groups (<0.05). However, the increase in the corneal HOAs in the FS-LASIK-CV group was less than the SMILE group (<0.05). At 3mo postoperatively, the logCS were better than preoperative levels under scotopic conditions without glare and scotopic conditions with glare in both groups (<0.05). At 1 and 3mo postoperatively, under scotopic conditions without glare and scotopic conditions with glare, FS-LASIK-CV group showed more improvement in logCS at two spatial frequencies (12.0 c/d and 18.0 c/d; <0.05).
Both FS-LASIK-CV and SMILE demonstrate to be safe, effective, and predictable in treatment of myopia and myopic astigmatism. Early postoperative improvement in UCVA and CSF at high spatial frequency under scotopic conditions were better after FS-LASIK-CV than SMILE.
比较地形图引导的飞秒激光原位角膜磨镶术(FS-LASIK-CV)和小切口基质透镜切除术(SMILE)治疗近视及近视散光早期阶段的视力质量结果。
对2019年4月至9月间49例行FS-LASIK(n = 23)或SMILE(n = 26)手术治疗近视及近视散光的患者进行回顾性对比分析。评估术前及术后的裸眼视力(UCVA)、等效球镜度(SEQ)、柱镜度、对比敏感度函数(CSF)及角膜高阶像差(HOAs)。组间比较采用独立样本t检验,不同时间点变化分析采用重复测量方差分析。
两组中,100%的术眼术后1周、1个月及3个月时UCVA达到20/20或更好。术后1天及3个月时,FS-LASIK-CV组UCVA优于SMILE组。术后1周时,SMILE组SEQ低于FS-LASIK-CV组(P = 0.006)。术后3个月时,两组SEQ均达到目标屈光度。两组残余散光均降低,组间无差异(P>0.05)。术后3个月时,两组6mm瞳孔直径下的球差和彗差均高于术前水平(P<0.05)。然而,FS-LASIK-CV组角膜HOAs增加幅度小于SMILE组(P<0.05)。术后3个月时,两组在暗视无眩光及暗视有眩光条件下logCS均优于术前水平(P<0.05)。术后1个月及3个月时,在暗视无眩光及暗视有眩光条件下,FS-LASIK-CV组在两个空间频率(12.0 c/d和18.0 c/d;P<0.05)的logCS改善更明显。
FS-LASIK-CV和SMILE在治疗近视及近视散光方面均安全、有效且可预测。FS-LASIK-CV术后早期UCVA及暗视条件下高空间频率CSF的改善优于SMILE。